tDCS + Cognitive Therapy for Stroke-related Cognitive Impairment
(TRAINS Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine whether a non-invasive brain stimulation technique, transcranial direct current stimulation (tDCS), combined with traditional cognitive therapy will improve cognitive function in patients with subacute stroke.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment tDCS for stroke-related cognitive impairment?
Research shows that combining transcranial direct current stimulation (tDCS) with cognitive training can improve cognitive tasks in stroke survivors, although the specific added benefit of tDCS alone is not clear. Some studies suggest improvements in daily activities and cognitive functions when tDCS is used with other therapies.12345
Is transcranial direct current stimulation (tDCS) safe for humans?
How is the treatment tDCS + Cognitive Therapy different from other treatments for stroke-related cognitive impairment?
The treatment combines transcranial direct current stimulation (tDCS), which uses a mild electrical current to stimulate specific brain areas, with cognitive therapy to potentially enhance cognitive function in stroke patients. This approach is unique because it targets brain activity directly and is used alongside cognitive exercises, unlike traditional therapies that may focus solely on cognitive exercises or medication.123511
Research Team
Kelly Sloane, MD
Principal Investigator
University of Pennsylvania
Roy Hamilton, PhD
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for individuals aged 18-90 who've had a stroke within the last 4 weeks and are now experiencing cognitive issues because of it. They must understand the study, follow simple commands, and not have serious neurological conditions (other than stroke), seizures, substance abuse problems, severe psychiatric disorders, unstable medical illnesses or metallic objects in their head.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 5 daily sessions of transcranial direct current stimulation (tDCS) paired with cognitive therapy
Follow-up
Participants are monitored for changes in cognitive performance after treatment
Treatment Details
Interventions
- tDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor